Zymeworks Inc
NYSE:ZYME
Zymeworks Inc
Total Liabilities
Zymeworks Inc
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zymeworks Inc
NYSE:ZYME
|
Total Liabilities
$116.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Total Liabilities
$96.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
33%
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Total Liabilities
$41.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Total Liabilities
$63.4m
|
CAGR 3-Years
58%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Total Liabilities
$157.2m
|
CAGR 3-Years
50%
|
CAGR 5-Years
44%
|
CAGR 10-Years
34%
|
|
Spectral Medical Inc
TSX:EDT
|
Total Liabilities
CA$25m
|
CAGR 3-Years
43%
|
CAGR 5-Years
74%
|
CAGR 10-Years
23%
|
See Also
What is Zymeworks Inc's Total Liabilities?
Total Liabilities
116.1m
USD
Based on the financial report for Dec 31, 2023, Zymeworks Inc's Total Liabilities amounts to 116.1m USD.
What is Zymeworks Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
13%
Over the last year, the Total Liabilities growth was -25%. The average annual Total Liabilities growth rates for Zymeworks Inc have been -3% over the past three years , 13% over the past five years .